share_log

UBS Downgrades Cano Health to Sell, Lowers Price Target to $3.75

Benzinga ·  Nov 17, 2023 10:48

UBS analyst Andrew Mok downgrades Cano Health (NYSE:CANO) from Neutral to Sell and lowers the price target from $12 to $3.75.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment